T80.89
Other complications following infusion, transfusion and therapeutic injection
Clinical Classification Guidelines
Use Additional Code
- code to identify graft-versus-host reaction, if applicable, (D89.81-)
Inclusion Terms
- Delayed serologic transfusion reaction (DSTR), unspecified incompatibility
Medical Intelligence & Overview
ICD-10 code T80.89 refers to other complications that may occur after medical procedures such as infusions, transfusions, or therapeutic injections. These complications can range from mild to severe and often involve unforeseen immune responses or reactions to the substances introduced into the body. One common example categorized under this code is the delayed serologic transfusion reaction (DSTR), which occurs when a patient's immune system responds to transfused blood components after some time has passed. Recognizing these potential issues is vital for healthcare providers to ensure proper management and patient safety.
Causes & Symptoms
Clinical Causes: Incompatibility between donor and recipient blood types or other blood components Immune responses to transfused blood or medication components Administration of contaminated or improperly prepared infusion solutions Delayed immune response leading to reactions days after the procedure Underlying immune system sensitivities or conditions that predispose to reactions Errors in blood matching or crossmatching procedures
Key Symptoms: Fever and chills occurring days after infusion or transfusion Skin rashes, hives, or itching Pain or swelling at the injection site or in other parts of the body Dark-colored urine or signs of hemolysis Shortness of breath or difficulty breathing Fatigue or malaise Nausea or abdominal discomfort Unusual bleeding or signs of internal bleeding
Diagnostic & Treatment
Diagnosis Path: Diagnosing complications coded under T80.89 involves a combination of clinical evaluation and laboratory testing. Healthcare providers may perform blood tests to identify hemolysis or other immune responses, assess compatibility, and rule out infections or other causes. Monitoring the patient's symptoms closely and reviewing the history of recent infusions or transfusions are crucial steps in confirming the diagnosis. Additional tests such as direct antiglobulin tests (DAT) or blood screenings are often utilized to detect incompatibilities and immune reactions.
Treatment Protocols: Discontinuing or withholding the suspected infusion or transfusion Administering antihistamines, corticosteroids, or other medications to control allergic reactions Providing supportive care such as hydration and oxygen therapy for respiratory concerns Managing hemolytic reactions with medications and, in severe cases, additional blood products or therapies Monitoring vital signs and organ function closely Preventive measures, including thorough crossmatching and compatibility testing before future procedures
Clinical Advice & FAQs
Billing Guidance
Is T80.89 a billable ICD-10 code?
Yes, T80.89 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report T80.89?
Clinical documentation must specify the nature of Other complications following infusion, transfusion and therapeutic injection and any associated comorbidities for accurate reporting.
Cite this Clinical Reference